There were 124 press releases posted in the last 24 hours and 437,635 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Neurocrine Biosciences and Voyager Therapeutics Announce Publication of Phase 1b Trial Results of VY-AADC for Parkinson’s Disease in the Annals of Neurology

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image